Skip to main content

US ClosedU.S. Closed

CTOR: Citius Oncology, Inc. Stock Analysis | finqOS

Healthcare · Medical - Pharmaceuticals

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types.

52W Range

16thpctl

Volume

0.25×avg

Market Cap

72.12MUSD

P/E Ratio

-1.6TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Citius Oncology, Inc.

CTORNASDAQ Global Market·USD·Closed

Citius Oncology, Inc.

CTORNASDAQ·USD·Closed

$0.78

−1.86%

$0.78

−$0.01 (1.86%)

52W Range

16thpctl

Volume

0.25×avg

Mkt Cap

72.12MUSD

P/E

-1.6TTM

Div Yield

–ann